Cite

HARVARD Citation

    Agnelli, G. et al. (2020). ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months. Thrombosis research. pp. 297-304. [Online]. 
  
Back to record